Companies › SNYR
SYNERGY CHC CORP (SNYR)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001562733 · EDGAR filings · Updated 2026-07-01
SYNERGY CHC CORP (SNYR) has reported institutional ownership of 14.8%, with 12 institutional managers holding positions valued at $2.16M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Latest updates
- 2026-07-01 — Insider transaction reported (Form 4)
- 2026-07-01 — Insider transaction reported (Form 4)
- 2026-07-01 — Insider transaction reported (Form 4)
- 2026-06-29 — Current report (8-K) filed
- 2026-05-22 — EFFECT filed
- 2026-05-21 — CORRESP filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, SYNERGY CHC CORP has 12 institutional holders and institutional ownership of 14.8%.
Insider activity
Insiders reported 72 transactions (72 buys, 0 sells) across 1 reporting insiders, with a net reported value of $159.6K.
Data flags from SEC filings
Related companies
IMPACT BIOMEDICAL INC (IBO) · Outlook Therapeutics Inc (OTLK) · Q/C TECHNOLOGIES INC (QCLS) · VIVOS THERAPEUTICS INC (VVOS) · Reviva Pharmaceuticals Holdings Inc (RVPH) · RADIOPHARM THERANOSTICS LTD (RADX)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-01.